Search Results

Filter
  • 1-10 of  381 results for ""Adaptor Proteins, Signal Transducing""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Editorial & Opinion

Lymphoma immunotherapy: the garden of forking paths.

Subjects: Adaptor Proteins, Signal Transducing* ; T-Lymphocytes*

  • Source: Blood [Blood] 2024 Feb 22; Vol. 143 (8), pp. 655-657.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020

Record details

×
Academic Journal

Population dynamics of immunological synapse formation induced by bispecific T cell engagers predict clinical pharmacodynamics and treatment resistance.

  • Authors : Liu C; Division of Pharmacotherapy and Experimental Therapeutics, School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, United States.; Zhou J

Subjects: Immunological Synapses* ; T-Lymphocytes*; Humans

  • Source: ELife [Elife] 2023 Jul 25; Vol. 12. Date of Electronic Publication: 2023 Jul 25.Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

Novel xeno-free and serum-free culturing condition to improve piggyBac transposon-based CD19 chimeric antigen receptor T-cell production and characteristics.

  • Authors : Sanyanusin M; Medical Microbiology, Interdisciplinary and International Program, Graduate School, Chulalongkorn University, Bangkok, Thailand.; Tudsamran S

Subjects: T-Lymphocytes* ; Receptors, Chimeric Antigen*/Receptors, Chimeric Antigen*/Receptors, Chimeric Antigen*/genetics ; Receptors, Chimeric Antigen*/Receptors, Chimeric Antigen*/Receptors, Chimeric Antigen*/metabolism

  • Source: Cytotherapy [Cytotherapy] 2023 Apr; Vol. 25 (4), pp. 397-406. Date of Electronic Publication: 2022 Dec 13.Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566

Record details

×
Academic Journal

GFAP and NfL increase during neurotoxicity from high baseline levels in pediatric CD19-CAR T-cell patients.

  • Authors : Gust J; Division of Pediatric Neurology, Department of Neurology, University of Washington, Seattle, WA.; Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA.

Subjects: T-Lymphocytes* ; Neurotoxicity Syndromes*/Neurotoxicity Syndromes*/Neurotoxicity Syndromes*/diagnosis ; Neurotoxicity Syndromes*/Neurotoxicity Syndromes*/Neurotoxicity Syndromes*/etiology

  • Source: Blood advances [Blood Adv] 2023 Mar 28; Vol. 7 (6), pp. 1001-1010.Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Long-term persistence and functionality of adoptively transferred antigen-specific T cells with genetically ablated PD-1 expression.

  • Authors : Dötsch S; Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, 81675 Munich, Germany.; Svec M

Subjects: T-Lymphocytes* ; Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/genetics; Animals

  • Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2023 Mar 07; Vol. 120 (10), pp. e2200626120. Date of Electronic Publication: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Characterization of Leukemic Resistance to CD19-Targeted CAR T-cell Therapy through Deep Genomic Sequencing.

  • Authors : Chen GM; Graduate Group in Genomics and Computational Biology, University of Pennsylvania, Philadelphia, Pennsylvania.; Chen CH

Subjects: Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/methods ; T-Lymphocytes*; Humans

  • Source: Cancer immunology research [Cancer Immunol Res] 2023 Jan 03; Vol. 11 (1), pp. 13-19.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Deregulated phospholipase D2/mammalian target of rapamycin/hypoxia-inducible factor 1 alpha in peripheral T lymphocytes of oral lichen planus correlated with disease severity.

  • Authors : Wang F; The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University, PR China.; Zhang J

Subjects: Hypoxia-Inducible Factor 1, alpha Subunit/Hypoxia-Inducible Factor 1, alpha Subunit/Hypoxia-Inducible Factor 1, alpha Subunit/*metabolism ; Lichen Planus, Oral/Lichen Planus, Oral/Lichen Planus, Oral/*immunology ; Phospholipase D/Phospholipase D/Phospholipase D/*metabolism

  • Source: Archives of oral biology [Arch Oral Biol] 2019 Feb; Vol. 98, pp. 26-31. Date of Electronic Publication: 2018 Nov 03.Publisher: Pergamon Press Country of Publication: England NLM ID: 0116711 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Filamin A Phosphorylation at Serine 2152 by the Serine/Threonine Kinase Ndr2 Controls TCR-Induced LFA-1 Activation in T Cells.

  • Authors : Waldt N; Institute of Molecular and Clinical Immunology, Health Campus Immunology, Infectiology and Inflammation (GC-I3), Otto-von-Guericke-University, Magdeburg, Germany.; Seifert A

Subjects: Filamins/Filamins/Filamins/*metabolism ; Lymphocyte Function-Associated Antigen-1/Lymphocyte Function-Associated Antigen-1/Lymphocyte Function-Associated Antigen-1/*metabolism ; Protein Serine-Threonine Kinases/Protein Serine-Threonine Kinases/Protein Serine-Threonine Kinases/*metabolism

  • Source: Frontiers in immunology [Front Immunol] 2018 Dec 04; Vol. 9, pp. 2852. Date of Electronic Publication: 2018 Dec 04 (Print Publication: 2018).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

CTLA-4Ig (abatacept) balances bone anabolic effects of T cells and Wnt-10b with antianabolic effects of osteoblastic sclerostin.

Subjects: Abatacept/Abatacept/Abatacept/*pharmacology ; Anabolic Agents/Anabolic Agents/Anabolic Agents/*pharmacology ; Bone and Bones/Bone and Bones/Bone and Bones/*drug effects

  • Source: Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2018 Mar; Vol. 1415 (1), pp. 21-33. Date of Electronic Publication: 2018 Mar 03.Publisher: New York Academy of Sciences Country of Publication: United States NLM ID: 7506858 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

[Regulatory effect of Vav1 on T cells and its relation to clinical diseases].

  • Authors : Zhang Y; Institute of Immunology, Zhejiang University School of Medicine, Hangzhou 310058, China.; Chen W

Subjects: Adaptor Proteins, Signal Transducing* ; Proto-Oncogene Proteins c-vav*/Proto-Oncogene Proteins c-vav*/Proto-Oncogene Proteins c-vav*/chemistry ; Proto-Oncogene Proteins c-vav*/Proto-Oncogene Proteins c-vav*/Proto-Oncogene Proteins c-vav*/immunology

  • Source: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences [Zhejiang Da Xue Xue Bao Yi Xue Ban] 2018 Jan 25; Vol. 47 (1), pp. 75-81.Publisher: Zhejiang da xue xue bao bian ji bu Country of Publication: China NLM ID: 100927946 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
  • 1-10 of  381 results for ""Adaptor Proteins, Signal Transducing""